Cell Bio Human Tech Co (318160.KQ) Stock Price
Cell Bio Human Tech Co Price
Revenue has compounded at 9.2% per year over the past 7 years to 51.07 B KRW. Earnings per share have declined at 1.2% per year over the last 7 years. Cell Bio Human Tech Co's net margin stands at 17.1%, up from 8.0% several years earlier.
Cell Bio Human Tech Co stock price
Cell Bio Human Tech Co business model & stock analysis
Frequently asked questions about Cell Bio Human Tech Co
Converted at the current exchange rate, the Cell Bio Human Tech Co share trades at 4.42 EUR (6,650.00 KRW).
The expected revenue of Cell Bio Human Tech Co is 62.00 B KRW. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Cell Bio Human Tech Co is 11.87 B KRW. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Cell Bio Human Tech Co is currently 4.56. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Cell Bio Human Tech Co stock.
The price-to-sales ratio (P/S) of Cell Bio Human Tech Co is currently 0.87. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Cell Bio Human Tech Co stock.
The Eulerpool Quality Score for Cell Bio Human Tech Co is 3/10.
The ISIN of Cell Bio Human Tech Co is KR7318160009. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Cell Bio Human Tech Co is 318160.KQ. The ticker symbol is used to trade Cell Bio Human Tech Co shares on the stock exchange.
Cell Bio Human Tech Co stock
Cell Bio Human Tech Co Peer Group
Cell Bio Human Tech Co FIGI
All fundamentals and in-depth analysis of Cell Bio Human Tech Co
Our stock analysis for Cell Bio Human Tech Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cell Bio Human Tech Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.